Physiological aspects of the renin-angiotensin system and peroral angiotensin converting enzyme inhibition
Aurell, M.
Scandinavian Journal of Urology and Nephrology. Supplementum 79: 9-12
1984
ISSN/ISBN: 0300-8886 PMID: 6089324 Document Number: 223354
Document emailed within 1 workday
Related Documents
Santucci, A.; Aguglia, F.; De Mattia, G.; Cammarella, I.; Trinchieri, F.; Giordano, M.; Gnecchi, M.; Ficara, C. 1983: Role of the renin-angiotensin-aldosterone system in ascitic hepatic cirrhosis. Effects of inhibition of angiotensin i converting enzyme La Clinica Terapeutica 106(2): 121-124Humke, U.; Levens, N.; Wood, J.; Hofbauer, K. 1992: The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system Journal of Pharmacology and Experimental Therapeutics 260(1): 29-35
Ganten, D.; Mullins, J.; Lindpaintner, K. 1989: The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors Journal of Human Hypertension 3(Suppl 1): 63-70
Novo, S.; Adamo, L.; Giamporcaro, A.; Forte, G.; Longo, B.; Gallo, V.B.; Licata, G.; Strano, A. 1987: Changes of angiotensin converting enzyme (ACE) levels during activation of the renin-angiotensin-aldosterone system (RAAs) Agents and Actions. Supplements 22: 339-347
Haznedaroğlu, I.C. 1997: Angiotensin I-converting enzyme, blood groups, and a local marrow-specific renin-angiotensin system Experimental Hematology 25(2): 93
Jasik, M.; Zdrojewicz, Z.; Stawicki, S. 1999: The activity of renin-angiotensin-aldosterone system (RAA) and possibilities of application angiotensin converting enzyme inhibitors (ACE I) in selected diseases of endocrine glands Wiadomosci Lekarskie 52(3-4): 202-210
Squire, I.B.; MacFayden, R.J.; Reid, J.L.; Devlin, A.; Lees, K.R. 1996: Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure Journal of Cardiovascular Pharmacology 27(5): 657-666
Inzhutova, A.I.; Salmina, A.B.; Petrova, M.M. 2007: Pronounced homeostatic action of angiotensin converting enzyme inhibitors with high affinity to tissue renin-angiotensin-aldosterone system on cellular membranes Kardiologiia 47(8): 49-52
Rasmussen, S.; Ibsen, H.; Giese, J. 1984: Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension Scandinavian Journal of Urology and Nephrology. Supplementum 79: 49-52
Oda, M.; Ino, Y.; Suzuki, K.; Sato, T.; Iwamoto, S.; Iwaki, M. 1989: Angiotensin converting enzyme inhibitory activity of MK-0521 in vivo and antihypertensive effect of its single oral administration on blood pressure and effect on the renin-angiotensin system in 2-kidney Goldblatt hypertensive dogs Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 93(4): 225-234
Kutkuhn, B.; Chlebowski, H.; Hollenbeck, M.; Grabensee, B. 1989: Conversion of inactive renin to active renin following acute angiotensin converting enzyme inhibition in essential hypertension and renovascular hypertension Zeitschrift für Kardiologie 78(3): 204-210
Matthews, P.G.; Johnston, C.I. 1979: Responses of the renin-angiotensin system and kallikrein-kinin system to sodium and converting enzyme inhibitor (SQ 14,225) Advances in Experimental Medicine and Biology 120b: 447-457
Goţia, S.; Stratone, A.; Neamţu, C.; Roşca, V.; Haulică, I. 1988: Renin and converting enzyme, components of an angiotensin-forming protease system, with reference to growing organisms Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 92(4): 725-728
Spinale, F.G.; Holzgrefe, H.H.; Mukherjee, R.; Webb, M.L.; Hird, R.B.; Cavallo, M.J.; Powell, J.R.; Koster, W.H. 1997: Angiotensin-converting enzyme inhibition and angiotensin Ii subtype-1 receptor blockade during the progression of left ventricular dysfunction: differential effects on myocyte contractile processes Journal of Pharmacology and Experimental Therapeutics 283(3): 1082-1094
Kondo, K.; Kida, O.; Kodama, K.; Higa, T.; Someya, N.; Morotomi, Y.; Tanaka, K. 1985: Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system Nihon Jinzo Gakkai Shi 27(3): 337-342
Campbell, D.J.; Anastasopoulos, F.; Duncan, A.M.; James, G.M.; Kladis, A.; Briscoe, T.A. 1998: Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats Journal of Pharmacology and Experimental Therapeutics 287(2): 567-577
Ripka, O.; Ort, J.; Linhartová, J.; Tvrzická, E.; Reinisová, J. 1972: Renin-angiotensin system in the diagnosis of renovascular hypertension. Radioimmunoassay of angiotensin i and angiotensin Ii Casopis Lekaru Ceskych 111(35): 818-820
Michel, B.; Grima, M.; Coquard, C.; Welsch, C.; Barthelmebs, M.; Imbs, J.L. 1993: Plasma renin activity and angiotensin converting enzyme of renal brush borders Archives des Maladies du Coeur et des Vaisseaux 86(8): 1245-1248
Biollaz, J.; Brunner, H.R.; Gavras, I.; Waeber, B.; Gavras, H. 1982: Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade Journal of Cardiovascular Pharmacology 4(6): 966-972
Brunner, H.R.; Waeber, B.; Nussberger, J. 1987: Angiotensin converting enzyme inhibition and the normal kidney Kidney International. Suppl 20: S104-S107